FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

716073005: Lumacaftor (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2016. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3304650012 Lumacaftor (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3304651011 Lumacaftor en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
1812981000195114 lumacaftor it Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
821721000172116 lumacaftor fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lumacaftor (substance) Is a Aminopyridine true Inferred relationship Some
Lumacaftor (substance) Is a Respiratory system agent (substance) true Inferred relationship Some
Lumacaftor (substance) Is a Benzodioxole (substance) true Inferred relationship Some
Lumacaftor (substance) Is a Substance with cystic fibrosis transmembrane conductance regulator potentiator mechanism of action (substance) true Inferred relationship Some
Lumacaftor (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Cystic fibrosis transmembrane conductance regulator potentiator (disposition) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing ivacaftor and lumacaftor (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lumacaftor (substance) Inferred relationship Some 2
Product containing ivacaftor and lumacaftor in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lumacaftor (substance) Inferred relationship Some 2
Product containing only ivacaftor and lumacaftor (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lumacaftor (substance) Inferred relationship Some 2
Product containing only ivacaftor and lumacaftor in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lumacaftor (substance) Inferred relationship Some 2

Reference Sets

Description inactivation indicator reference set

Back to Start